These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7956739)

  • 41. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
    Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.
    Kostrubsky VE; Vore M; Kindt E; Burliegh J; Rogers K; Peter G; Altrogge D; Sinz MW
    Drug Metab Dispos; 2001 Dec; 29(12):1561-6. PubMed ID: 11717175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans.
    Cox PJ; Ryan DA; Hollis FJ; Harris AM; Miller AK; Vousden M; Cowley H
    Drug Metab Dispos; 2000 Jul; 28(7):772-80. PubMed ID: 10859151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution and metabolism of the antipsychotic agent mazapertine succinate in rats.
    Caldwell GW; Wu WN; McKown LA; Diane Gauthier A; Masucci JA; Jones WJ; Leo GC; Reitz AB
    J Pharm Biomed Anal; 2006 May; 41(2):500-9. PubMed ID: 16386397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
    Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
    Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
    Tanis SP; Parker TT; Colca JR; Fisher RM; Kletzein RF
    J Med Chem; 1996 Dec; 39(26):5053-63. PubMed ID: 8978836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration.
    Mathews JM; deCosta K; Thomas BF
    Drug Metab Dispos; 1996 Jul; 24(7):702-10. PubMed ID: 8818565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism and disposition of sulfinalol in laboratory animals.
    Benziger DP; Fritz A; Edelson J
    Drug Metab Dispos; 1981; 9(6):493-8. PubMed ID: 6120804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of aminoglutethimide in the rat.
    Egger H; Bartlett F; Itterly W; Rodebaugh R; Shimanskas C
    Drug Metab Dispos; 1982; 10(4):405-12. PubMed ID: 6126342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
    Park YH; Jung BH; Chung BC; Park J; Mitoma C
    Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometry.
    Fouda HG; Lukaszewicz J; Clark DA; Hulin B
    Xenobiotica; 1991 Jul; 21(7):925-34. PubMed ID: 1776268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Species differences in pharmacokinetics of a hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7, after intravenous and oral administration to rats, rabbits, and dogs.
    Yoon WH; Yoo JK; Lee JW; Shim CK; Lee MG
    Drug Metab Dispos; 1998 Feb; 26(2):152-63. PubMed ID: 9456302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats.
    Koudriakova T; Iatsimirskaia E; Tulebaev S; Spetie D; Utkin I; Mullet D; Thompson T; Vouros P; Gerber N
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1300-9. PubMed ID: 8968354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.